{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:57:45Z","timestamp":1771469865411,"version":"3.50.1"},"reference-count":28,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Carriers of a single sickle cell gene mutation generally enjoy normal lifespans without serious health consequences related to their sickle cell status, but under extreme conditions such as severe dehydration and high-intensity physical activity, complications such as exertional rhabdomyolysis, splenic infarction, and papillary necrosis can occur. Recently, the National Collegiate Athletic Association (NCAA) adopted a policy that requires sickle cell solubility testing for all incoming student athletes. However, the American Society of Hematology (ASH) and other physician organizations oppose this policy. What is the basis for this controversy and how have new findings moved the field forward? I discuss herein the epidemiology, genetics, and clinical studies of sickle cell trait; review the implications of current policies regarding sickle cell trait screening and interventions for the student athlete; and examine additional areas where more information is needed.<\/jats:p>","DOI":"10.1182\/asheducation-2013.1.632","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T15:51:13Z","timestamp":1386345073000},"page":"632-637","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":31,"title":["Sickle cell trait testing and athletic participation: a solution in search of a problem?"],"prefix":"10.1182","volume":"2013","author":[{"given":"Alexis A.","family":"Thompson","sequence":"first","affiliation":[{"name":"Lurie Children's Hospital Chicago, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111702570723100_B1","doi-asserted-by":"crossref","first-page":"S435","DOI":"10.1016\/j.amepre.2011.09.012","article-title":"Public health implications of sickle cell trait: a report of the CDC meeting","volume":"41","author":"Grant","year":"2011","journal-title":"Am J Prev Med"},{"issue":"12","key":"2019111702570723100_B2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/ki.2011.286","article-title":"Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans","volume":"80","author":"Hicks","year":"2011","journal-title":"Kidney Int"},{"issue":"3","key":"2019111702570723100_B3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.2009070705","article-title":"High prevalence of sickle cell trait in African Americans with ESRD","volume":"21","author":"Derebail","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2019111702570723100_B4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks","volume":"110","author":"Austin","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111702570723100_B5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.08841209","article-title":"Sickle cell trait and development of microvascular complications in diabetes mellitus","volume":"5","author":"Bleyer","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019111702570723100_B6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/asheducation-2010.1.418","article-title":"Sickle-cell trait: novel clinical significance","volume":"2010","author":"Key","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"15","key":"2019111702570723100_B7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.110.004622","article-title":"Incidence of sudden cardiac death in national collegiate athletic association athletes","volume":"123","author":"Harmon","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"2019111702570723100_B8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.22271","article-title":"Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications","volume":"87","author":"Goldsmith","year":"2012","journal-title":"Am J Hematol"},{"issue":"11","key":"2019111702570723100_B9","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1249\/MSS.0b013e31826851c2","article-title":"ACSM and CHAMP summit on sickle cell trait: mitigating risks for warfighters and athletes","volume":"44","author":"O'Connor","year":"2012","journal-title":"Med Sci Sports Exerc"},{"issue":"13","key":"2019111702570723100_B10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM198709243171301","article-title":"Sickle-cell trait as a risk factor for sudden death in physical training","volume":"317","author":"Kark","year":"1987","journal-title":"N Engl J Med"},{"issue":"1-4","key":"2019111702570723100_B11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00007256-200838110-00004","article-title":"Physiological responses of sickle cell trait carriers during exercise","volume":"38","author":"Connes","year":"2008","journal-title":"Sports Med"},{"issue":"4","key":"2019111702570723100_B12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1152\/japplphysiol.01573.2011","article-title":"Effects of regular physical activity on skeletal muscle structural, energetic, and microvascular properties in carriers of sickle cell trait","volume":"113","author":"Vincent","year":"2012","journal-title":"J Appl Physiol"},{"key":"2019111702570723100_B13","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1152\/japplphysiol.01452.2011","article-title":"Exercise training blunts oxidative stress in sickle cell trait carriers","volume":"112","author":"Chirico","year":"2012","journal-title":"J Appl Physiol"},{"key":"2019111702570723100_B14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/CH-2011-1524","article-title":"Moderate endurance exercise is not a risk for rhabdomyolysis or renal failure in sickle cell trait carriers","volume":"51","author":"Messonnier","year":"2012","journal-title":"Clin Hemorheol Microcirc"},{"key":"2019111702570723100_B15","article-title":"Effects of hydration and water deprivation on blood viscosity during a soccer game in sickle cell trait carriers","author":"Diaw","journal-title":"Br J Sports Med"},{"issue":"5","key":"2019111702570723100_B16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bjsports-2011-090896","article-title":"Sickle cell trait associated with a RR of death of 37 times in National Collegiate Athletic Association football athletes: a database with 2 million athlete-years as the denominator","volume":"46","author":"Harmon","year":"2012","journal-title":"Br J Sports Med"},{"issue":"3","key":"2019111702570723100_B17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/CND.0b013e31822721ca","article-title":"Exertional rhabdomyolysis: a clinical review with a focus on genetic influences","volume":"13","author":"Landau","year":"2012","journal-title":"J Clin Neuromuscul Dis"},{"issue":"4","key":"2019111702570723100_B18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3810\/psm.2004.04.197","article-title":"Exertional rhabdomyolysis: early recognition is key","volume":"32","author":"Brown","year":"2004","journal-title":"Phys Sportsmed"},{"issue":"4","key":"2019111702570723100_B19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mus.21740","article-title":"Natural history of exertional rhabdomyolysis: a population-based analysis","volume":"42","author":"Alpers","year":"2010","journal-title":"Muscle Nerve"},{"issue":"3","key":"2019111702570723100_B20","first-page":"21","article-title":"Update: exertional rhabdomyolysis, active component, U.S. Armed Forces 2008-2012","volume":"20","year":"2013","journal-title":"MSMR"},{"issue":"8","key":"2019111702570723100_B21","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00421-013-2622-y","article-title":"Genetic polymorphisms associated with exertional rhabdomyolysis","volume":"113","author":"Deuster","year":"2013","journal-title":"Eur J Appl Physiol"},{"issue":"6","key":"2019111702570723100_B22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1399-0004.2009.01251.x","article-title":"The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility","volume":"76","author":"Sambuughin","year":"2009","journal-title":"Clin Genet"},{"issue":"21","key":"2019111702570723100_B23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood.V116.21.945.945","article-title":"Prevention of exercise-related death unexplained by preexisting disease associated with sickle cell trait (SCT) without hemoglobin screening or Hb specific management","volume":"116","author":"Kark","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111702570723100_B24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1249\/JSR.0b013e3181f1d183","article-title":"American College of Sports Medicine Roundtable on exertional heat stroke\u2013return to duty\/return to play: conference proceedings","volume":"9","author":"O'Connor","year":"2010","journal-title":"Curr Sports Med Rep"},{"issue":"6","key":"2019111702570723100_B25","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1016\/j.amepre.2011.09.014","article-title":"Screening U.S. college athletes for their sickle cell disease carrier status","volume":"41","author":"Jordan","year":"2011","journal-title":"Am J Prev Med"},{"issue":"3","key":"2019111702570723100_B26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2012-3680","article-title":"Committee on Bioethics, Committee on Genetics, The American College of Medical Genetics and Genomics Social, Ethical, and Legal Issues Committee, American Academy of Pediatrics. Policy statement: ethical and policy issues in genetic testing and screening of children","volume":"131","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"2019111702570723100_B27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/gim.2012.176","article-title":"Technical report: Ethical and policy issues in genetic testing and screening of children","volume":"15","author":"Ross","year":"2013","journal-title":"Genet Med"},{"issue":"5","key":"2019111702570723100_B28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bjsports-2011-090521","article-title":"Sudden exertional death in sickle cell trait","volume":"46","author":"Loosemore","year":"2012","journal-title":"Br J Sports Med"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2013\/1\/632\/1249745\/bep00113000632.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2013\/1\/632\/1249745\/bep00113000632.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T17:05:37Z","timestamp":1597165537000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2013\/1\/632\/20758\/Sickle-cell-trait-testing-and-athletic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2013.1.632","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,6]]}}}